Compass therapeutics to participate in the h.c. wainwright 2nd annual bioconnect investor conference

Boston, may 14, 2024 (globe newswire) --  compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the company will participate in a fireside chat at the h.c. wainwright 2nd annual bioconnect investor conference taking place in new york city, ny on may 20, 2024.
CMPX Ratings Summary
CMPX Quant Ranking